Brad Dickerson

Bradley Dickerson currently serves as the Vice President of Project Management & Patient Advocacy at iECURE, inc., a position held since February 2022. Prior to this role, Bradley was the President of BJD Life Science Consulting from September 2021 to February 2022, and the Chief Commercial Officer at Palvella Therapeutics from October 2020 to August 2021, where responsibilities included building the commercial organization for new treatments in rare genodermatoses. Bradley's extensive experience also includes positions such as General Manager Americas at Aurinia Pharmaceuticals, where efforts focused on launch readiness and market access strategies, and senior roles at RX Crossroads Specialty Solutions, Shire (formerly NPS Pharmaceuticals), NPS Pharmaceuticals, ViroPharma Incorporated, and Wyeth, which involved leadership in market access, patient services, and commercialization of pharmaceutical products. Bradley holds a Bachelor of Arts degree in Management and Business Administration from Gettysburg College, earned between 1997 and 2001.